Soleno Therapeutics Inc (NASDAQ: SLNO) kicked off on Tuesday, up 6.26% from the previous trading day, before settling in for the closing price of $58.45. Over the past 52 weeks, SLNO has traded in a range of $41.50-$90.32.
Annual sales at Healthcare sector company grew by 20.19% over the past five years. While this was happening, its average annual earnings per share was recorded 84.53%. With a float of $46.02 million, this company’s outstanding shares have now reached $50.44 million.
Let’s look at the performance matrix of the company that is accounted for 92 employees.
Soleno Therapeutics Inc (SLNO) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Soleno Therapeutics Inc is 13.40%, while institutional ownership is 96.94%. The most recent insider transaction that took place on Aug 11 ’25, was worth 110,696,581. Before that another transaction happened on Jul 01 ’25, when Company’s insider sold 3,830 for $82.76, making the entire transaction worth $316,971. This insider now owns 13,206 shares in total.
Soleno Therapeutics Inc (SLNO) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -1.83 earnings per share (EPS), lower than consensus estimate (set at -0.61) by -1.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.34 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 84.53% per share during the next fiscal year.
Soleno Therapeutics Inc (NASDAQ: SLNO) Trading Performance Indicators
Take a look at Soleno Therapeutics Inc’s (SLNO) current performance indicators. Last quarter, stock had a quick ratio of 15.01. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 101.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.15, a number that is poised to hit 0.05 in the next quarter and is forecasted to reach 3.05 in one year’s time.
Technical Analysis of Soleno Therapeutics Inc (SLNO)
Soleno Therapeutics Inc (NASDAQ: SLNO) saw its 5-day average volume 1.82 million, a positive change from its year-to-date volume of 1.29 million. As of the previous 9 days, the stock’s Stochastic %D was 33.35%.
During the past 100 days, Soleno Therapeutics Inc’s (SLNO) raw stochastic average was set at 31.88%, which indicates a significant decrease from 63.10% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.16 in the past 14 days, which was higher than the 3.37 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $68.39, while its 200-day Moving Average is $65.06. Nevertheless, the first resistance level for the watch stands at $63.57 in the near term. At $65.02, the stock is likely to face the second major resistance level. The third major resistance level sits at $66.65. If the price goes on to break the first support level at $60.48, it is likely to go to the next support level at $58.85. Assuming the price breaks the second support level, the third support level stands at $57.40.
Soleno Therapeutics Inc (NASDAQ: SLNO) Key Stats
The company with the Market Capitalisation of 3.30 billion has total of 53,145K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -175,850 K annual income. Company’s last quarter sales were recorded 32,660 K and last quarter income was -4,710 K.
